title: Mechanisms by which chronic ethanol feeding impairs the migratory capacity of cutaneous dendritic cells.
abstract: BACKGROUND
  Chronic alcoholism is associated with increased incidence and severity of skin infection. Cutaneous dendritic cells (CDCs) play a pivotal role in skin immunity, and chronic ethanol (EtOH) feeding in mice has been shown to inhibit CDC migration to skin-draining lymph nodes (dLNs) following epicutaneous sensitization. Because CDC subsets differentially initiate T-cell responses, it is important to determine how EtOH feeding affects migration of each subset and identify mechanisms responsible for observed defects.
  
  
  METHODS
  Mice received EtOH in the drinking water for ≥ 16 weeks. Baseline numbers of CDC subsets and their migration to the dLNs following fluorescein 5-isothiocyanate (FITC) sensitization were assessed by flow cytometry. Epidermal cell suspension and skin explant cultures were used to measure the impact of EtOH upon molecules that influence CDC migration. Cytokine arrays performed on explant culture supernatants assessed local production of inflammatory cytokines.
  
  
  RESULTS
  Chronic EtOH feeding reduced migration of all CDC subsets to the dLNs following FITC sensitization. Reduced migration of dermal-resident CDCs did not correspond with reduced baseline numbers of these cells. For Langerhans cells (LCs), EtOH-induced migratory dysfunction corresponded with delayed down-regulation of E-cadherin, chemokine receptor 1 (CCR1), and CCR6 and impaired up-regulation of matrix metalloproteinases (MMPs) 2 and 9. In skin explant assays, EtOH blunted CDC mobilization following stimulation with CCL21/CPG 1826. No alteration in CD54 or CCR7 expression was observed, but production of skin-derived tumor necrosis factor alpha (TNF-α) was reduced. Poor migratory responses in vitro could be improved by supplementing explant cultures from EtOH-fed mice with TNF-α.
  
  
  CONCLUSIONS
  Chronic EtOH consumption does not alter baseline dermal-resident CDC numbers. However, like LCs, migratory responsiveness of dermal CDCs was decreased following FITC sensitization. Inefficient down-regulation of both CCRs and adhesion molecules and the inability to up-regulate MMPs indicate that EtOH impedes LC acquisition of a promigratory phenotype. These defects, combined with improvement of the migratory defect with in vitro TNF-α replacement, demonstrate intrinsic as well as environmental contributions to defective CDC migration. These findings provide novel mechanisms to explain the observed increased incidence and severity of skin infections in chronic alcoholics.
authors.affiliation: Department of Pathology and Interdisciplinary Graduate Program in Immunology , University of Iowa Carver College of Medicine, Iowa City, Iowa.
authors.forename: Corey P
authors.initials: CP
authors.lastname: Parlet
authors.forename: Annette J
authors.initials: AJ
authors.lastname: Schlueter
mesh_terms: D000818:Animals; D002465:Cell Movement / Q000187:drug effects; D002478:Cells, Cultured; D016207:Cytokines / Q000032:analysis; D000431:Ethanol / Q000008:administration & dosage*; D005260:Female; D015870:Gene Expression / Q000187:drug effects; D018799:Intercellular Adhesion Molecule-1 / Q000235:genetics; D007801:Langerhans Cells / Q000737:chemistry / Q000187:drug effects* / Q000502:physiology*; D020782:Matrix Metalloproteinases / Q000235:genetics; D051379:Mice; D008810:Mice, Inbred C57BL; D054400:Receptors, CCR7 / Q000235:genetics; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
chemical_list: C515371:Ccr7 protein, mouse; D016207:Cytokines; D054400:Receptors, CCR7; D014409:Tumor Necrosis Factor-alpha; D018799:Intercellular Adhesion Molecule-1; D000431:Ethanol; D020782:Matrix Metalloproteinases
keywords: Cutaneous Dendritic Cells; Langerhans Cells; Matrix Metalloproteinases; Migration; TNF-α
references.citation: J Immunol. 1999 Jan 1;162(1):277-83
references.pmid: 9886396
references.citation: Alcohol Clin Exp Res. 2008 Apr;32(4):657-68
references.pmid: 18241312
references.citation: Histol Histopathol. 2008 Jul;23(7):897-910
references.pmid: 18437688
references.citation: Proc Natl Acad Sci U S A. 2006 May 16;103(20):7783-8
references.pmid: 16672373
references.citation: J Am Acad Dermatol. 2000 Jul;43(1 Pt 1):1-16; quiz 16-8
references.pmid: 10863217
references.citation: J Leukoc Biol. 2006 May;79(5):941-53
references.pmid: 16478920
references.citation: J Exp Med. 2007 Dec 24;204(13):3133-46
references.pmid: 18086862
references.citation: Cell Immunol. 1994 Oct 15;158(2):389-99
references.pmid: 7923390
references.citation: J Clin Invest. 2010 May;120(5):1762-73
references.pmid: 20364087
references.citation: J Immunol. 2008 Jul 1;181(1):641-8
references.pmid: 18566431
references.citation: J Immunol. 2012 May 1;188(9):4334-9
references.pmid: 22442445
references.citation: J Immunol. 2002 May 1;168(9):4361-71
references.pmid: 11970978
references.citation: Immunology. 1995 Jan;84(1):31-5
references.pmid: 7890303
references.citation: Eur J Immunol. 2001 Oct;31(10):3085-93
references.pmid: 11592085
references.citation: Immunity. 2004 Aug;21(2):279-88
references.pmid: 15308107
references.citation: Int Immunol. 2000 Jun;12(6):737-45
references.pmid: 10837401
references.citation: J Invest Dermatol. 2012 Mar;132(3 Pt 2):872-81
references.pmid: 22217741
references.citation: Alcohol Clin Exp Res. 1998 Dec;22(9):1927-42
references.pmid: 9884135
references.citation: Immunobiology. 2010 Sep-Oct;215(9-10):770-9
references.pmid: 20599290
references.citation: Immunol Cell Biol. 2010 May-Jun;88(4):424-30
references.pmid: 20368713
references.citation: J Exp Med. 2007 Dec 24;204(13):3147-56
references.pmid: 18086865
references.citation: Alcohol Clin Exp Res. 2011 Jan;35(1):47-59
references.pmid: 21039629
references.citation: J Exp Med. 2003 Aug 18;198(4):615-21
references.pmid: 12925677
references.citation: J Immunol. 1997 Dec 15;159(12):6148-55
references.pmid: 9550416
references.citation: J Leukoc Biol. 2009 Jan;85(1):34-43
references.pmid: 18820175
references.citation: J Leukoc Biol. 1999 Jul;66(1):33-9
references.pmid: 10410987
references.citation: J Dermatol Sci. 2007 Jan;45(1):23-30
references.pmid: 17123788
references.citation: J Leukoc Biol. 2002 Dec;72(6):1109-16
references.pmid: 12488491
references.citation: Alcohol. 2007 Aug;41(5):357-69
references.pmid: 17889312
references.citation: PLoS Pathog. 2009 Dec;5(12):e1000703
references.pmid: 20041174
references.citation: Alcohol Clin Exp Res. 1991 Feb;15(1):16-22
references.pmid: 2024729
references.citation: J Leukoc Biol. 1999 Sep;66(3):462-70
references.pmid: 10496317
references.citation: Alcohol Clin Exp Res. 2007 Oct;31(10):1746-58
references.pmid: 17681030
references.citation: Clin Microbiol Infect. 2006 Apr;12(4):345-52
references.pmid: 16524411
references.citation: Alcohol Clin Exp Res. 2010 Sep 1;34(9):1489-511
references.pmid: 20586763
references.citation: J Immunol. 1999 Mar 1;162(5):2472-5
references.pmid: 10072485
references.citation: J Exp Med. 2007 Dec 24;204(13):3119-31
references.pmid: 18086861
references.citation: Arch Dermatol Res. 2009 Jan;301(1):87-91
references.pmid: 18825399
references.citation: Nat Immunol. 2009 May;10(5):488-95
references.pmid: 19349986
references.citation: J Immunol. 2004 Sep 1;173(5):3398-407
references.pmid: 15322204
references.citation: J Exp Med. 1999 Feb 1;189(3):451-60
references.pmid: 9927507
references.citation: Int J Immunopharmacol. 2000 Apr;22(4):285-98
references.pmid: 10689102
references.citation: Proc Soc Exp Biol Med. 1993 Nov;204(2):184-90
references.pmid: 8415774
references.citation: Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3312-7
references.pmid: 19218433
references.citation: Immunol Rev. 2010 Mar;234(1):55-75
references.pmid: 20193012
references.citation: Immunobiology. 2008;213(9-10):715-28
references.pmid: 18926287
references.citation: Alcohol Clin Exp Res. 2007 May;31(5):846-54
references.pmid: 17386065
references.citation: Alcohol Clin Exp Res. 1992 Jun;16(3):474-9
references.pmid: 1626648
references.citation: Immunity. 2011 Aug 26;35(2):260-72
references.pmid: 21782478
references.citation: Immunity. 2008 Sep 19;29(3):325-42
references.pmid: 18799141
references.citation: Immunity. 2005 May;22(5):643-54
references.pmid: 15894281